Duck virus hepatitis: serial passage of attenuated virus in ducklings
Woolcock, P.R.; Crighton, G.W.
Veterinary Record 105(2): 30-32
1979
ISSN/ISBN: 0042-4900 PMID: 233456 Document Number: 145878
The safety of three attenuated virus vaccines of proven efficacy against duck virus hepatitis was assessed by controlled laboratory studies which involved the serial transmission of the virus through groups of 2-day-old ducklings known to be susceptible to the disease. Each vaccine was initially derived from a different source. Enhancement of virulence which resulted in deaths from the disease in test groups of ducklings occurred in each instance.
Document emailed within 1 workday
Related Documents
Hanson, L.E.; Tripathy, D.N. 1976: Oral immunization of ducklings with attenuated duck hepatitis virus Developments in Biological Standardization 33: 357-363Toth, T.E. 1970: Active immunization of White Pekin ducks against duck virus enteritis (duck plague) with modified-live-virus vaccine: immunization of ducklings American Journal of Veterinary Research 31(7): 1275-1281
Price, W.H.; Casals, J.; Thind, I.; O'Leary, W. 1973: Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate) American Journal of Tropical Medicine and Hygiene 22(4): 509-523
Chun, H.; T'eh-chang, H.; Kuo-hua, T.; Shou-teh, C.; Wen-huan, W.; Chi-ming, C.; Yu-fen, K.; Chü-yeh, Y.; Lan, H. 1975: Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture Chinese Medical Journal 1(4): 283-286
Thind, I.S. 1981: Attenuated Langat E5 virus as a live virus vaccine against Kyasanur Forest disease virus Indian Journal of Medical Research 73: 141-149
Zuffa, T. 1987: The growth of attenuated strains of canine parvovirus, mink enteritis virus, feline panleukopenia virus, and rabies virus on various types of cell cultures Veterinarni Medicina 32(10): 633-640
Diamandopoulos, G.T.; Miller, M.H.; McLane, M.F.; Evans, P.G. 1976: Loss or persistence of the differentiated state of simian virus 40-induced hamster tumor cells before and after serial passage in culture Cancer Research 36(9 Pt.1): 3171-3177
Chen, L.B.; Chen, P.L.; Wang, G.L.; Song, X.T.; Li, Y.F.; Liu, C.Y.; Jia, K.M. 1990: Ultrastructural study of hepatitis B virus in biliary epithelial cells of duck liver Chinese Medical Journal 103(6): 447-450
Mi, Z.; Chen, H.; Zhang, X.; Shao, X.; Li, Z.; Wu, X. 1995: Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs Chinese Medical Journal 108(9): 660-664
Guo, Y-Fei.; Cheng, A-Chun.; Wang, M-Shu.; Jia, R-Yong.; Wen, M.; Zhou, W-Guang.; Zhou, Y.; Chen, X-Yue. 2008: Studies on the propagation characteristics of duck plague virulent virus in duck embryo fibroblasts Bing du Xue Bao 24(5): 352-357
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Fleury, H.J.; Babin, M.; Bonnici, J.F.; Poveda, J.D.; Beyrie, M.; Vuillaume, A.; Alexander, D.J. 1986: First simultaneous isolation of influenza A virus and duck enteritis virus from commercial ducks in France Veterinary Record 119(9): 208-209
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Huang, X.; Cao, Y.; Tan, S. 2001: Horizontal transmission of live attenuated hepatitis a vaccine virus Zhonghua Yi Xue Za Zhi 81(8): 465-467
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240